Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

71%

5 of 7 completed trials have results

Key Signals

1 recruiting5 with results

Enrollment Performance

Analytics

N/A
5(83.3%)
Phase 1
1(16.7%)
6Total
N/A(5)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT06788977Recruiting

External Trigeminal Nerve Stimulation for Migraine Treatment in Pregnancy

Role: lead

NCT03465904Not ApplicableCompleted

A Phase III Trial of e-TNS for the Acute Treatment of Migraine

Role: lead

NCT02546362Not ApplicableCompleted

Cefaly® Device in the Treatment of Patients With Fibromyalgia.

Role: lead

NCT02342743Not ApplicableCompleted

Open-trial on the Prevention of Chronic Migraines With the CEFALY Device

Role: lead

NCT03217968Not ApplicableCompleted

Abortive Treatment of Migraine With the Cefaly® Abortive Program Device

Role: lead

NCT02590939Not ApplicableCompleted

Acute Treatment of Migraine With e-TNS

Role: lead

NCT02616978Completed

Retrospective Study on the Use of CEFALY® Device During Migraine Attacks

Role: lead

NCT02411513Phase 1Completed

Acute Treatment of Migraine Using the CEFALY Device

Role: lead

All 8 trials loaded